Search

Displaying results 2151 - 2160 of 7058 in total
  1. Drug

    Glasmacinal

    go.drugbank.com/drugs/DB21722
    Experimental

    Glasmacinal is a small molecule drug. Glasmacinal has a monoisotopic molecular weight of 694.44 Da.

  2. Drug

    Linustedastat

    go.drugbank.com/drugs/DB21729
    Experimental

    Linustedastat is a small molecule drug. Linustedastat has a monoisotopic molecular weight of 453.22 Da.

  3. Drug

    Evening primrose oil

    go.drugbank.com/drugs/DB11358
    ApprovedNutraceutical

    [A33131] Evening primrose oil has been filled for the FDA by Humanetics Corporation on April 2000 to be a new dietary ingredient but its current status is "Inadequate basis for expectation of safety".

    Products: GNC EVENING PRIMROSE OIL 1300MG WITH GLA & LA
  4. Drug

    Strawberry

    go.drugbank.com/drugs/DB10571
    Approved

    Strawberry allergenic extract is used in allergenic testing.

    Mixtures: Extrait De Fraises
  5. Drug

    Mirvetuximab soravtansine

    go.drugbank.com/drugs/DB12489
    ApprovedInvestigational

    Mirvetuximab soravtansine-gynx (IMGN853) is an antibody-drug conjugate (ADC) formed by a monoclonal antibody (M9346A) that targets folate receptor alpha (FRα), covalently joined by a cleavable disulfide … [A254392,L43967] DM4 is conjugated to the antibody with a drug-to-antibody ratio of 3.5:1.

  6. Drug

    Gamolenic acid

    go.drugbank.com/drugs/DB13854
    ApprovedWithdrawn

    It is converted to [DB00154], a biosynthetic precursor of monoenoic prostaglandins such as PGE1.

    Mixtures: Hi-GA Evening Primerose Oil Liq
  7. Drug

    Zenocutuzumab

    go.drugbank.com/drugs/DB15559
    ApprovedInvestigational

    [L56179] This approval was expedited following receipt of an FDA Commissioner’s National Priority Voucher. … Zenocutuzumab is a low-fucose humanized full-length immunoglobulin G1 (IgG1) bispecific HER2- and HER3-directed bispecific antibody.

  8. Drug

    Venetoclax

    go.drugbank.com/drugs/DB11581
    ApprovedInvestigational

    Venetoclax is a BCL-2 inhibitor that was initially approved by the FDA in April 2016 [FDA label]. … prior therapy [FDA label].

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  9. Drug

    Poliglusam

    go.drugbank.com/drugs/DB11234
    ApprovedInvestigational

    Poliglusam, or chitosan, is a linear polysaccharide consisting of D-glucosamine and N-acetyl-D-glucosamine. … As a rich source of dietary fiber, chitosan is used as a food ingredient or additive.

    Mixtures: Anbiser B-HA Hyaluronic Acid Nourishing ConditionerCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Metiazinic acid

    go.drugbank.com/drugs/DB19572
    Experimental

    Metiazinic acid is a small molecule drug. Metiazinic acid has a monoisotopic molecular weight of 271.07 Da.